One Capital Management LLC Sells 10,290 Shares of Koninklijke Philips (NYSE:PHG)

One Capital Management LLC decreased its position in shares of Koninklijke Philips (NYSE:PHG) by 3.4% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 288,043 shares of the technology company’s stock after selling 10,290 shares during the quarter. One Capital Management LLC’s holdings in Koninklijke Philips were worth $7,259,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. Mondrian Investment Partners LTD boosted its stake in Koninklijke Philips by 45.1% during the 1st quarter. Mondrian Investment Partners LTD now owns 9,553,058 shares of the technology company’s stock worth $191,061,000 after acquiring an additional 2,971,008 shares during the last quarter. Dimensional Fund Advisors LP boosted its stake in Koninklijke Philips by 27.3% during the 2nd quarter. Dimensional Fund Advisors LP now owns 4,036,336 shares of the technology company’s stock worth $101,718,000 after acquiring an additional 864,951 shares during the last quarter. Russell Investments Group Ltd. boosted its stake in Koninklijke Philips by 36.4% during the 1st quarter. Russell Investments Group Ltd. now owns 1,410,067 shares of the technology company’s stock worth $28,201,000 after acquiring an additional 376,244 shares during the last quarter. Brandes Investment Partners LP boosted its stake in Koninklijke Philips by 48.7% during the 4th quarter. Brandes Investment Partners LP now owns 1,285,935 shares of the technology company’s stock worth $30,001,000 after acquiring an additional 421,055 shares during the last quarter. Finally, Natixis Advisors LLC boosted its stake in Koninklijke Philips by 5.2% during the 2nd quarter. Natixis Advisors LLC now owns 930,085 shares of the technology company’s stock worth $23,438,000 after acquiring an additional 46,268 shares during the last quarter. Institutional investors own 13.67% of the company’s stock.

Koninklijke Philips Stock Performance

Shares of PHG opened at $30.74 on Monday. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.74 and a current ratio of 1.16. Koninklijke Philips has a twelve month low of $17.75 and a twelve month high of $30.91. The firm’s 50 day moving average price is $28.44 and its two-hundred day moving average price is $25.40. The firm has a market cap of $28.89 billion, a P/E ratio of -32.02, a PEG ratio of 1.05 and a beta of 0.73.

Koninklijke Philips (NYSE:PHG) last announced its quarterly earnings results on Monday, July 29th. The technology company reported $0.32 earnings per share for the quarter. Koninklijke Philips had a negative net margin of 2.35% and a positive return on equity of 10.15%. The firm had revenue of $4.80 billion for the quarter. On average, analysts forecast that Koninklijke Philips will post 1.5 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Separately, StockNews.com raised shares of Koninklijke Philips from a “hold” rating to a “buy” rating in a research note on Monday, July 15th. Three research analysts have rated the stock with a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold”.

Koninklijke Philips Company Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.